Vaninder Dhillon/hopkinsmedicine.org
Feb 23, 2026, 16:49
Unpacking Genetic Markers for Thyroid Nodule Risks – Johns Hopkins Medicine
Johns Hopkins Medicine shared a post on LinkedIn։
“Is molecular testing in thyroid nodules helpful?
Dr. Vaninder Dhillon breaks down the latest debate from the AAO-HNSF 2025 meeting, exploring how genetic markers are reshaping risk assessment and treatment decisions.”
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 29, 2026, 19:40The Great Egg Escape: Understanding Premature Ovulation in IVF – Fertility Plus
-
May 29, 2026, 19:38Devyanshi Dixit: Call for Abstract for GFWH 2026
-
May 29, 2026, 19:35Tom Holland: Advancing Robotic Surgery Skills at the T400 Course in Strasbourg
-
May 29, 2026, 19:33Silpi Saikia: Not Every Successful Blastocyst Comes From an Easy Case!
-
May 29, 2026, 19:31Register Now and Secure Your Spot at ASRM 2026 – ASRM
-
May 29, 2026, 19:29Sonam Jain: The Real Driver of IVF Conversion Is Patient Trust
-
May 29, 2026, 19:26Mediterranean Diet Before IVF Increases Successful Pregnancies by 40%! – Fertility Plus
-
May 29, 2026, 19:24Melanie Norton: Excited to Begin My Robotics Fellowship at UCLH
-
May 29, 2026, 19:22A Step Forward in Non-Invasive Diagnosis of Endometriosis – The Lancet Medical Imaging and Theranostics